keyword
https://read.qxmd.com/read/38758415/a-systematic-review-of-the-perspectives-of-botulinum-toxin-use-on-the-quality-of-life-of-neurological-patients-with-drooling
#1
REVIEW
Michelle Almeida Silva, Márcia Maria Fonseca da Silveira, Bruna Rafaele Vieira Pedrosa, Rebeka Thiara Nascimento Thiara Dos Santos, Zilda Betânia Barbosa Medeiros de Farias, Ana Paula Veras Sobral
OBJECTIVE: To investigate the effectiveness of botulinum toxin in the salivary glands of patients with neurological impairment and drooling and its impact on the quality of life. MATERIALS AND METHODS: This systematic review was registered with the International Prospective Register of Systematic Reviews (CRD 42,023,435,242) and conducted using the Preferred Reporting Items for Systematic Reviews and Meta-analyses. An electronic search was performed in the PubMed/MEDLINE, Embase, Scopus, Cochrane Library, and clinical trial databases until August 2023, no language restriction...
May 17, 2024: Clinical Oral Investigations
https://read.qxmd.com/read/38740417/pediatric-sialorrhea-drooling
#2
REVIEW
Karan Gandhi, Julie E Strychowsky, Breanna A Chen
No abstract text is available yet for this article.
May 12, 2024: Canadian Medical Association Journal: CMAJ
https://read.qxmd.com/read/38729239/upper-airway-manifestations-of-anti-iglon5-disease-otorhinolaryngological-point-of-view
#3
JOURNAL ARTICLE
Daniela Pastene, Eduardo Lehrer, Sara Jubes, Joan Santamaria, Alex Iranzo, Carles Gaig, Isabel Vilaseca
INTRODUCTION: Anti-IgLON5 disease is a recently described neurological disorder with multisystemic features. The disease is characterized by the presence of IgLON5 antibodies in serum and cerebrospinal fluid. Our objective is to describe in detail the otorhinolaryngological manifestations of this disease, which are frequent and may include dysphagia, dysarthria, vocal cord paralysis and laryngospasm. METHODS: In this study, we present a series of 9 patients with anti-IgLON5 disease and otolaryngological manifestations...
May 8, 2024: Acta otorrinolaringologica española
https://read.qxmd.com/read/38713070/clozapine-efficacy-and-adverse-drug-reactions-among-a-nationwide-study-of-1021-australians-prescribed-clozapine-the-clozagene-study
#4
JOURNAL ARTICLE
Penelope A Lind, Richard K Parker, Korinne Northwood, Dan J Siskind, Sarah E Medland
BACKGROUND AND HYPOTHESIS: The ClozaGene Study is a nationwide cohort of adults who have been treated with clozapine. While clozapine is indicated in the management of treatment-resistant schizophrenia, it is associated with a considerable adverse drug reaction (ADR) burden, and not all patients achieve adequate symptomatic response. The current study focuses on self-reported experiences of clozapine use and response, clozapine-associated ADRs, and mental health comorbidity. STUDY DESIGN: A total of 1021 participants (41...
May 7, 2024: Schizophrenia Bulletin
https://read.qxmd.com/read/38690447/botulinum-toxin-type-a-in-the-treatment-of-raynaud-s-syndrome-a-case-report
#5
Plamen Penchev, Valentin Dobrev, Petar-Preslav Petrov, Remzi Hyusein, Vladislav Velchev, Kristiyan Georgiev
Raynaud's syndrome is characterized by paroxysmal vasospasm in the digital arterioles, following exposure to cold or stress. Pain, swelling, stiffness, and hypoesthesia are observed as manifestations. The presence of a trophic ulcer is accompanied by a range of severe manifestations. The assaults occur in three distinct phases, namely vasospastic, plethoric, and erythema. Various approaches improve the overall well-being of a patient. It is possible to differentiate between primary and secondary Raynaud's syndrome, the latter being linked to systemic diseases...
March 2024: Curēus
https://read.qxmd.com/read/38689457/parkinson-s-disease-the-dentist-s-role-as-part-of-the-healthcare-team
#6
JOURNAL ARTICLE
Liliana Ortiz Camacho, Leila Jahangiri, Jenna Iseringhausen, Gary R Goldstein
Parkinson's disease is a neurodegenerative disease that results in patients exhibiting uncontrolled movements, changes in saliva production, and difficulty in swallowing and speech. Understanding the staging of the disease and the available therapies allows dentists to treat these patients safely and with compassion to meet their oral health care needs for an optimal quality of life. This appraisal discusses Parkinson's disease as it relates to clinically relevant facts to manage and treat the oral health care needs of these patients in the short and long term including general dental care recommendations...
April 30, 2024: Journal of Prosthodontics: Official Journal of the American College of Prosthodontists
https://read.qxmd.com/read/38679061/role-of-fiberoptic-endoscopic-evaluation-of-swallowing-fees-in-children-with-suspected-dysphagia
#7
JOURNAL ARTICLE
Débora Bressan Pazinatto, Maria Angela Bellomo Brandão, Flávia Lima Peixoto Costa, Myrian Maria Andreotti Favaro, Rebecca Maunsell
OBJECTIVE: To assess FEES findings in defining oral feeding safety in children with suspected dysphagia, comparing them with clinical feeding evaluation results. METHODS: This study comprised a case series involving children with suspected dysphagia, referred for evaluation by otolaryngologists and speech-language pathologists (SLPs) at a Brazilian quaternary public university hospital. These children underwent both clinical evaluations and fiberoptic endoscopic evaluation of swallowing (FEES), with a comprehensive collection of demographic and clinical data...
April 25, 2024: Jornal de Pediatria
https://read.qxmd.com/read/38668374/the-positive-effect-of-adenotonsillectomy-on-drooling-in-children
#8
JOURNAL ARTICLE
Orna Katz Kadosh, Orna Sever, Oshrat Sella Weiss, Ari DeRowe, Riva Tauman
OBJECTIVES: (1) To investigate the prevalence and severity of drooling among healthy young children referred for adenotonsillectomy; (2) to evaluate the effect of adenotonsillectomy on drooling. STUDY DESIGN: Prospective study. SETTING: Tertiary referral center. METHODS: Healthy typically developed children aged 18 to 48 months referred to adenotonsillectomy for upper airway obstruction (UAO) were recruited. Age-matched children recruited from the community served as controls...
April 26, 2024: Otolaryngology—Head and Neck Surgery
https://read.qxmd.com/read/38655996/management-of-sialorrhea-in-children-a-systematic-review
#9
JOURNAL ARTICLE
Manuela Leitão de Vasconcelos, Divany Guedes Pereira da Cunha, Giorvan Ânderson Dos Santos Alves, Tatiana Carneiro da Cunha Almeida Santos, Luiz Medeiros de Araujo Lima-Filho, Karinna Veríssimo Meira Taveira, Cristiano Miranda de Araújo, Leandro Pernambuco
No abstract text is available yet for this article.
2024: Revista da Associação Médica Brasileira
https://read.qxmd.com/read/38645944/magnetic-resonance-imaging-in-rabies-encephalitis-a-case-report-and-review-of-the-literature
#10
Abasin Tajmalzai, Ataullah Zarabi
Rabies is an acute fatal disease of the central nervous system. Neuroimaging plays an important role, especially in establishing an early diagnosis and distinguishing it from other types of encephalitis. This case report aims to give a brief review of this condition and report the less common MRI findings of the disease. We herein report a case of a 61-year-old male bitten by a stray dog who presented with fever, vomiting, headache, sialorrhea, dysarthria, dysphagia, and upper limb weakness which progressed to lower limbs on the next day...
July 2024: Radiology Case Reports
https://read.qxmd.com/read/38634369/polymorphisms-in-erbb4-and-tacr1-associated-with-dry-mouth-in-clozapine-treated-patients
#11
JOURNAL ARTICLE
Hanna Puolakka, Anssi Solismaa, Leo-Pekka Lyytikäinen, Merja Viikki, Niko Seppälä, Nina Mononen, Terho Lehtimäki, Olli Kampman
OBJECTIVE: Sialorrhea is a common and uncomfortable adverse effect of clozapine, and its severity varies between patients. The aim of the study was to select broadly genes related to the regulation of salivation and study associations between sialorrhea and dry mouth and polymorphisms in the selected genes. METHODS: The study population consists of 237 clozapine-treated patients, of which 172 were genotyped. Associations between sialorrhea and dry mouth with age, sex, BMI, smoking, clozapine dose, clozapine and norclozapine serum levels, and other comedication were studied...
April 18, 2024: Acta Neuropsychiatrica
https://read.qxmd.com/read/38633105/profile-of-patients-with-maxillofacial-space-infections-and-associated-risk-factors
#12
JOURNAL ARTICLE
Srikanth Gadicherla, Kirti Manglani, Kalyana C Pentapati, Adarsh Kudva, Chithra Aramanadka, Rajaji Chandravel
OBJECTIVE: To evaluate the profile of patients operated for maxillofacial space infections and associated risk factors for the length of hospital stay. MATERIALS AND METHODS: We conducted a retrospective study among patients operated for maxillofacial infections at our center from 2010 to 2020. Information collected from the records were age, sex, type and number of spaces involved, clinical signs and symptoms (pain, swelling, toothache, sore throat, otalgia, hoarseness, headache, cough, neck swelling, rancid breath, sialorrhea, gingival swelling, muffled voice, trismus, fever, dysphagia, odynophagia, malaise, lymphadenopathy, dyspnoea, pus discharge), treatment modality, total leukocyte count, evidence of bacterial growth, comorbidities, complications if any and length of hospital stay...
2024: TheScientificWorldJournal
https://read.qxmd.com/read/38608010/clozapine-treatment-for-aggressive-behaviors-in-youths-with-neurodevelopmental-disorders
#13
JOURNAL ARTICLE
Stefano Berloffa, Gabriele Masi, Francesca Falcone, Valerio Simonelli, Antonio Narzisi, Elena Valente, Valentina Viglione, Annarita Milone, Gianluca Sesso
Objectives: The aim of this study was to assess effectiveness and tolerability of Clozapine in the treatment of aggression in youth with Neurodevelopmental Disorders. Methods: Patients were consecutively admitted at our third-level university hospital with nationwide catchment from June 2018 to October 2022, and followed up to July 2023. Eligibility criteria were as follows: (1) Autism Spectrum Disorder (ASD) and/or Intellectual Disability/Borderline Cognitive Functioning, (2) behavioral dyscontrol with physical aggression; (3) age range between 8 and 18 years; (4) clinical indication for Clozapine treatment after at least two failed trials with other Second-Generation Antipsychotics (SGAs); (5) availability of an at least 6-month-long follow-up...
April 2024: Journal of Child and Adolescent Psychopharmacology
https://read.qxmd.com/read/38577753/effectiveness-of-atropine-in-managing-sialorrhea-a-systematic-review-and-meta-analysis
#14
JOURNAL ARTICLE
Venkata K Yellepeddi, Jonathan A Race, Mary M McFarland, Jonathan E Constance, Elika Fanaeian, Nancy A Murphy
OBJECTIVES: To describe the efficacy of atropine in controlling salivary flow in patients with sialorrhea or drooling. MATERIALS AND METHODS: We included randomized controlled studies, quasi-randomized trials, case reports, clinical trials, systematic reviews, and meta-analyses assessing the use of atropine in patients with sialorrhea or drooling. The endpoints were reduction in salivary flow rate, amount of saliva secreted, reduction in clinical symptoms of sialorrhea, death rattle intensity, or reduction in drooling intensity as measured by an objective scale such as the drooling intensity scale...
April 5, 2024: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/38537033/the-state-of-the-art-in-therapeutic-administration-of-botulinum-toxin-in-children-with-cerebral-palsy-an-integrative-review
#15
JOURNAL ARTICLE
Sandro Rachevsky Dorf, Adriana Rodrigues Fonseca, Flávio Roberto Sztajnbok, Thiffany Rodrigues Delfino de Oliveira, Linamara Rizzo Basttistella
OBJECTIVE: To describe the current state of the art in the therapeutic administration of botulinum toxin with indications, efficacy, and safety profile for children and adolescents with cerebral palsy. DATA SOURCE: An integrative review was conducted. The MEDLINE/PubMed database was searched twice within the last decade using distinct terms, and only studies written in the English language were included. The study population was limited to those aged 0-18 years...
2024: Revista Paulista de Pediatria: Orgão Oficial da Sociedade de Pediatria de São Paulo
https://read.qxmd.com/read/38524401/amyotrophic-lateral-sclerosis-and-pain-a-narrative-review-from-pain-assessment-to-therapy
#16
REVIEW
Vincenzo Pota, Pasquale Sansone, Sara De Sarno, Caterina Aurilio, Francesco Coppolino, Manlio Barbarisi, Francesco Barbato, Marco Fiore, Gianluigi Cosenza, Maria Beatrice Passavanti, Maria Caterina Pace
Amyotrophic lateral sclerosis (ALS) is the most frequent neurodegenerative disease of the motor system that affects upper and lower motor neurons, leading to progressive muscle weakness, spasticity, atrophy, and respiratory failure, with a life expectancy of 2-5 years after symptom onset. In addition to motor symptoms, patients with ALS have a multitude of nonmotor symptoms; in fact, it is currently considered a multisystem disease. The purpose of our narrative review is to evaluate the different types of pain, the correlation between pain and the disease's stages, the pain assessment tools in ALS patients, and the available therapies focusing above all on the benefits of cannabis use...
2024: Behavioural Neurology
https://read.qxmd.com/read/38492517/deep-brain-stimulation-of-the-subthalamic-nucleus-increases-the-risk-of-sialorrhea-in-patients-with-advanced-parkinson-s-disease
#17
JOURNAL ARTICLE
Jinxing Sun, Lian Cheng, Zhenke Li, Junheng Jia, Qianqian Wu, Ying Hou, Qi Wang, Guangjian Zhang, Hong Wang, Xingang Li, Weiguo Li, Chao Zhang
INTRODUCTION: Sialorrhea is a common neurological manifestation of Parkinson's disease (PD). No specifically designed prospective study has tested the effects of deep brain stimulation of the subthalamic nucleus (STN-DBS) on sialorrhea in patients with advanced PD. We focused on the effect of STN-DBS on the incidence of sialorrhea in patients with PD. METHODS: This multicenter, prospective, non-randomized concurrent clinical trial analyzed the incidence of sialorrhea during long-term follow-up in 170 patients with advanced PD (84 patients with STN-DBS and 86 patients with medication therapy)...
March 9, 2024: Parkinsonism & related Disorders
https://read.qxmd.com/read/38470068/european-academy-of-neurology-ean-guideline-on-the-management-of-amyotrophic-lateral-sclerosis-in-collaboration-with-european-reference-network-for-neuromuscular-diseases-ern-euro-nmd
#18
JOURNAL ARTICLE
Philip Van Damme, Ammar Al-Chalabi, Peter M Andersen, Adriano Chiò, Philippe Couratier, Mamede De Carvalho, Orla Hardiman, Magdalena Kuźma-Kozakiewicz, Albert Ludolph, Christopher J McDermott, Jesus S Mora, Susanne Petri, Katrin Probyn, Evy Reviers, François Salachas, Vincenzo Silani, Ole-Bjørn Tysnes, Leonard H van den Berg, Gemma Villanueva, Markus Weber
BACKGROUND: This update of the guideline on the management of amyotrophic lateral sclerosis (ALS) was commissioned by the European Academy of Neurology (EAN) and prepared in collaboration with the European Reference Network for Neuromuscular Diseases (ERN EURO-NMD) and the support of the European Network for the Cure ALS (ENCALS) and the European Organization for Professionals and Patients with ALS (EUpALS). METHODS: Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology was used to assess the effectiveness of interventions for ALS...
March 12, 2024: European Journal of Neurology
https://read.qxmd.com/read/38465898/gingival-squamous-cell-carcinoma-in-2-lions-under-managed-care
#19
JOURNAL ARTICLE
Hisadora A S C Bom, Telma S Lima, Silvio M C Fonseca, Givaldo B Silva Filho, Nathalia S Wicpolt, Jeann L Araújo, Dênisson S Souza, Márcio A Silva, Brian G Murphy, Javier Asin, Francisco A Uzal, Fábio S Mendonça, Eileen E Henderson
Neoplasia is one of the main causes of euthanasia in geriatric captive nondomestic felids. However, few studies have examined oral tumors in these animals. We describe here the clinicopathologic features of gingival squamous cell carcinoma (SCC) in 2 lions ( Panthera leo ) from separate zoologic collections. In both cases, the lions had a history of sialorrhea, bloody oral discharge, and anorexia. Autopsy findings in both lions were similar and were characterized by poorly circumscribed, friable, and bloody gingival masses with grossly apparent invasion of the mandibular bone; a pathologic fracture was observed in 1 case...
March 11, 2024: Journal of Veterinary Diagnostic Investigation
https://read.qxmd.com/read/38465519/clinical-pharmacokinetics-of-atropine-oral-gel-formulation-in-healthy-volunteers
#20
JOURNAL ARTICLE
Madison Parrot, Bhuvanesh Yathavan, Olga Averin, Logan Hoggard, Joseph E Rower, Michael Voight, Danielle Greene, Ariel Tarrell, Aviva Whelan, Hamidreza Ghandehari, Nancy Murphy, Venkata Yellepeddi
Sialorrhea or drooling is a common problem in children and adults with neurodevelopmental disorders. It can negatively impact the quality of life due to its physical and psychological manifestations. Providers commonly prescribe atropine eye drops for topical administration to the oral mucosa, as an off-label treatment to manage sialorrhea. However, the off-label use of atropine eye drops can be associated with medication and dosing errors and systemic side effects. To address these limitations of treatment, we developed a mucoadhesive topical oral gel formulation of atropine as an alternative route to off-label administration of atropine eye drops...
March 2024: Clinical and Translational Science
keyword
keyword
6609
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.